Company intelligence / Profile preview

Dedalus

Florence, Tuscany, Italydedalus.com ↗

Ownership: Public · FR0000052623
Development stage: Commercial

Overview

Dedalus delivers healthcare and diagnostic software to public and private institutions globally. Its platforms support patient management, clinical workflows, diagnostics, and data interoperability across the continuum of care. The company's technology underpins digital transformation in healthcare systems serving over 540 million people daily. No clinical results as it does not conduct drug trials.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Works with numerous hospitals and health systems globally

Financials

Market cap: $6M
Total revenue: $29.6M
Enterprise value: $5.7M

Beyond the preview

Go deeper on Dedalus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dedalus.

Explore the full profile